GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Scandinavian Real Heart HEART.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

16.40

-1.80%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Scandinavian Real Heart

Its shares trade on Nasdaq Stockholm under the ticker HEART.ST. It has been listed since 26 November 2014. In the fiscal year to 31 December 2022, it reported revenue of SEK 10,000 and a net loss of SEK 14.0m. At that date it held total assets of SEK 119.8m and shareholders' equity of SEK 97.6m.

Scandinavian Real Heart AB engages in the development of mechanical cardiac pumps. The company is headquartered in Vasteras, Vastmanland. The company went IPO on 2014-11-26. The firm conducts research and development of a cardiac pump function for patients awaiting heart transplants.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
26 Nov 2014

Leadership

Pay as last reported

  • Klaus Gustav Göran Hellers, MD, PhDChairman, since 2013
  • Gunnar NihlénDirector, since 2008
  • Azad Najar, MDChief Executive Officer & Director, since 2007
  • Susanne HedmanChief Financial Officer & Director, since 2011
  • Azad Najar, MDChief Executive Officer & Director, since 2008
  • Susanne HedmanChief Financial Officer & Director, since 2011
  • Ernst Lennat WestmanDirector, since 2018
  • Harold Peter KaiserDirector, since 2017

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Vasteras, Vastmanland, Sweden
  • Develops mechanical cardiac pumps for heart transplant patients
  • Conducted IPO on 2014-11-26

Weaknesses

  • No specific weaknesses mentioned in the provided information
  • No financial data provided for analysis
  • No market share or competitive position details

Opportunities

  • Potential growth in cardiac pump technology for heart transplant patients
  • Expansion of R&D activities for cardiac pump functions
  • Increased demand for mechanical cardiac pumps in healthcare

Threats

  • Dependence on R&D for cardiac pump development
  • Competition in the health care sector
  • No information on regulatory or market threats

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.